Jia Jie Biomedical Co Ltd (4109) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jia Jie Biomedical Co Ltd (4109) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$12.96 Million ≈ $408.15K USD) by net assets (NT$1.70 Billion ≈ $53.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jia Jie Biomedical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Jia Jie Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Jia Jie Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jia Jie Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jia Jie Biomedical Co Ltd ranked by their cash flow conversion efficiency. Explore Jia Jie Biomedical Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dongyang Expre
KO:084670
|
0.059x |
|
Theralase Technologies Inc.
V:TLT
|
-0.180x |
|
Ananda Development Public Company Limited
BK:ANAN
|
0.067x |
|
Hastings Technology Metals Ltd
AU:HAS
|
-0.035x |
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
-0.370x |
|
Uangel
KO:072130
|
0.044x |
|
Aerodrome Group Ltd
TA:ARDM
|
-0.166x |
|
Bestec Power Electronics Co Ltd
TW:3308
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Jia Jie Biomedical Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Jia Jie Biomedical Co Ltd from 2015 to 2025. View today's stock price for Jia Jie Biomedical Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.71 Billion ≈ $54.00 Million |
NT$21.34 Million ≈ $672.42K |
0.012x | -61.83% |
| 2024-12-31 | NT$1.36 Billion ≈ $42.82 Million |
NT$44.35 Million ≈ $1.40 Million |
0.033x | +878.02% |
| 2023-12-31 | NT$1.07 Billion ≈ $33.72 Million |
NT$-4.49 Million ≈ $-141.40K |
-0.004x | +55.86% |
| 2022-12-31 | NT$923.96 Million ≈ $29.11 Million |
NT$-8.78 Million ≈ $-276.56K |
-0.010x | -303.12% |
| 2021-12-31 | NT$934.93 Million ≈ $29.46 Million |
NT$4.37 Million ≈ $137.77K |
0.005x | -84.33% |
| 2020-12-31 | NT$907.97 Million ≈ $28.61 Million |
NT$27.10 Million ≈ $853.80K |
0.030x | -16.07% |
| 2019-12-31 | NT$694.88 Million ≈ $21.89 Million |
NT$24.71 Million ≈ $778.56K |
0.036x | +293.94% |
| 2018-12-31 | NT$714.19 Million ≈ $22.50 Million |
NT$-13.10 Million ≈ $-412.60K |
-0.018x | +6.56% |
| 2017-12-31 | NT$699.60 Million ≈ $22.04 Million |
NT$-13.73 Million ≈ $-432.54K |
-0.020x | +75.32% |
| 2016-12-31 | NT$962.54 Million ≈ $30.33 Million |
NT$-76.54 Million ≈ $-2.41 Million |
-0.080x | -195.08% |
| 2015-12-31 | NT$983.23 Million ≈ $30.98 Million |
NT$82.22 Million ≈ $2.59 Million |
0.084x | -- |
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more